154 related articles for article (PubMed ID: 30796964)
1. L-Dopa decarboxylase interaction with the major signaling regulator ΡΙ3Κ in tissues and cells of neural and peripheral origin.
Vassiliou AG; Siaterli MZ; Frakolaki E; Gkogkosi P; Paspaltsis I; Sklaviadis T; Vassilacopoulou D; Vassilaki N
Biochimie; 2019 May; 160():76-87. PubMed ID: 30796964
[TBL] [Abstract][Full Text] [Related]
2. Human L-Dopa decarboxylase interaction with annexin V and expression during apoptosis.
Chalatsa I; Arvanitis N; Arvanitis D; Tsakou AC; Kalantzis ED; Vassiliou AG; Sideris DC; Frakolaki E; Vassilaki N; Vassilacopoulou D
Biochimie; 2020 Oct; 177():78-86. PubMed ID: 32835737
[TBL] [Abstract][Full Text] [Related]
3. Emerging Role of l-Dopa Decarboxylase in Flaviviridae Virus Infections.
Frakolaki E; Kalliampakou KI; Kaimou P; Moraiti M; Kolaitis N; Boleti H; Koskinas J; Vassilacopoulou D; Vassilaki N
Cells; 2019 Aug; 8(8):. PubMed ID: 31387309
[TBL] [Abstract][Full Text] [Related]
4. Human L-DOPA decarboxylase mRNA is a target of miR-145: A prediction to validation workflow.
Papadopoulos EI; Fragoulis EG; Scorilas A
Gene; 2015 Jan; 554(2):174-80. PubMed ID: 25445287
[TBL] [Abstract][Full Text] [Related]
5. L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinoma.
Papadopoulos EI; Petraki C; Gregorakis A; Chra E; Fragoulis EG; Scorilas A
Clin Biochem; 2015 Jun; 48(9):590-5. PubMed ID: 25721989
[TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing reveals alternative L-DOPA decarboxylase (DDC) splice variants bearing novel exons, in human hepatocellular and lung cancer cells.
Papatsirou M; Adamopoulos PG; Artemaki PI; Georganti VP; Scorilas A; Vassilacopoulou D; Kontos CK
Gene; 2021 Feb; 768():145262. PubMed ID: 33141052
[TBL] [Abstract][Full Text] [Related]
7. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.
Ciesielska A; Sharma N; Beyer J; Forsayeth J; Bankiewicz K
PLoS One; 2015; 10(4):e0122708. PubMed ID: 25860990
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.
Colamartino M; Padua L; Meneghini C; Leone S; Cornetta T; Testa A; Cozzi R
DNA Cell Biol; 2012 Nov; 31(11):1572-9. PubMed ID: 23020119
[TBL] [Abstract][Full Text] [Related]
9. Molecular characteristic and physiological role of DOPA-decarboxylase.
Guenter J; Lenartowski R
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1424-1440. PubMed ID: 28100850
[TBL] [Abstract][Full Text] [Related]
10. Use of radiolabeled monofluoromethyl-Dopa to define the subunit structure of human L-Dopa decarboxylase.
Maneckjee R; Baylin SB
Biochemistry; 1983 Dec; 22(26):6058-63. PubMed ID: 6661425
[TBL] [Abstract][Full Text] [Related]
11. Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression.
Wafa LA; Cheng H; Plaa N; Ghaidi F; Fukumoto T; Fazli L; Gleave ME; Cox ME; Rennie PS
Int J Cancer; 2012 Jun; 130(12):2835-44. PubMed ID: 21780103
[TBL] [Abstract][Full Text] [Related]
12. Production of Dopamine by Aromatic l-Amino Acid Decarboxylase Cells after Spinal Cord Injury.
Ren LQ; Wienecke J; Hultborn H; Zhang M
J Neurotrauma; 2016 Jun; 33(12):1150-60. PubMed ID: 26830512
[TBL] [Abstract][Full Text] [Related]
13. L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of
Tremmel E; Kuhn C; Kaltofen T; Vilsmaier T; Mayr D; Mahner S; Ditsch N; Jeschke U; Vattai A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334070
[TBL] [Abstract][Full Text] [Related]
14. DDC expression is not regulated by NFAT5 (TonEBP) in dopaminergic neural cell lines.
Pineda-Cirera L; Cabana-Domínguez J; Benetó N; Diez H; Arenas C; Cormand B; Fernàndez-Castillo N
Gene; 2020 Jun; 742():144569. PubMed ID: 32165301
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure and substrate specificity of Drosophila 3,4-dihydroxyphenylalanine decarboxylase.
Han Q; Ding H; Robinson H; Christensen BM; Li J
PLoS One; 2010 Jan; 5(1):e8826. PubMed ID: 20098687
[TBL] [Abstract][Full Text] [Related]
16. Columbamine suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK1/2 MAPK signaling pathways.
Lin Z; Li S; Guo P; Wang L; Zheng L; Yan Z; Chen X; Cheng Z; Yan H; Zheng C; Zhao C
Life Sci; 2019 Feb; 218():197-204. PubMed ID: 30582951
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
[TBL] [Abstract][Full Text] [Related]
18. Developmental expression and spatial distribution of dopa decarboxylase in Drosophila.
Konrad KD; Marsh JL
Dev Biol; 1987 Jul; 122(1):172-85. PubMed ID: 3297852
[TBL] [Abstract][Full Text] [Related]
19. Biochemical identification of residues that discriminate between 3,4-dihydroxyphenylalanine decarboxylase and 3,4-dihydroxyphenylacetaldehyde synthase-mediated reactions.
Liang J; Han Q; Ding H; Li J
Insect Biochem Mol Biol; 2017 Dec; 91():34-43. PubMed ID: 29037755
[TBL] [Abstract][Full Text] [Related]
20. Revised Exon Structure of l-DOPA Decarboxylase (
Artemaki PI; Papatsirou M; Boti MA; Adamopoulos PG; Christodoulou S; Vassilacopoulou D; Scorilas A; Kontos CK
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]